Drug intelligence / Profile preview

Allium ascalonicum

Development stage: Unknown
Administration: Oral

Overview

Allium ascalonicum, or shallot, is a plant used both as a food ingredient and for its medicinal properties. It contains sulfur compounds like alliin, which transforms into allicin when crushed, providing antimicrobial and cardiovascular benefits. Shallots also contain flavonoids such as quercetin and kaempferol, which have antioxidant and anti-inflammatory effects. They are traditionally used to support digestive health, boost immunity, and aid in cardiovascular well-being.

Other names: ShallotSpring onion (in some contexts)

Targets

SQLE (Squalene monooxygenase)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Allium ascalonicum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allium ascalonicum.

Explore the full profile